Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - vTv Therapeutics Inc. | vtvt-ex322_6.htm |
| EX-31.2 - EX-31.2 - vTv Therapeutics Inc. | vtvt-ex312_8.htm |
| EX-21.1 - EX-21.1 - vTv Therapeutics Inc. | vtvt-ex211_235.htm |
| EX-23.1 - EX-23.1 - vTv Therapeutics Inc. | vtvt-ex231_10.htm |
| EX-10.13 - EX-10.13 - vTv Therapeutics Inc. | vtvt-ex1013_629.htm |
| EX-31.1 - EX-31.1 - vTv Therapeutics Inc. | vtvt-ex311_9.htm |
| 10-K - 10-K - vTv Therapeutics Inc. | vtvt-10k_20151231.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of vTv Therapeutics Inc. (the “Company”) on Form 10-K for the period ended December 31, 2015 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stephen L. Holcombe, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in my capacity as an officer of the Company that, to my knowledge:
|
|
1. |
The Report fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934; and |
|
|
2. |
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Date: March 4, 2016
|
By: |
/s/ Stephen L. Holcombe |
|||
|
|
Stephen L. Holcombe |
|||
|
|
President and Chief Executive Officer |
|||